Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Oncologist|August 19, 2023
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal CancerEric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, et al.
International Emergency Nursing|March 26, 2022
The effectiveness of primary care streaming in emergency departments on decision-making and patient flow and safety - A realist evaluationMichelle Edwards, Alison Cooper, Thomas Hughes, et al.
Annals of Internal Medicine|July 7, 2020
Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical CenterMalathi Srinivasan, Steven Asch, Stacie Vilendrer, et al.
BMC Emergency Medicine|August 18, 2020
Emergency department clinical leads' experiences of implementing primary care services where GPs work in or alongside emergency departments in the UK: a qualitative studyMichelle Edwards, Alison Cooper, Freya Davies, et al.
BMJ Open|April 13, 2019
The impact of general practitioners working in or alongside emergency departments: a rapid realist reviewAlison Cooper, Freya Davies, Michelle Edwards, et al.
The Oncologist|February 22, 2023
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal CancerJosep Tabernero, Eric Van Cutsem, Elena Garralda, et al.
International Emergency Nursing|April 20, 2021
A classification of primary care streaming pathways in UK emergency departments: Findings from a multi-methods study comprising cross-sectional survey; site visits with observations, semi-structured and informal interviewsMichelle Edwards, Alison Cooper, Thomas Hughes, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 28, 2021
Identifying safe care processes when GPs work in or alongside emergency departments: a realist evaluationAlison Cooper, Andrew Carson-Stevens, Michelle Edwards, et al.
Nutrients|February 27, 2026
Lifelong n-3 PUFA Consumption Reduces HER2+ Mammary Tumour Growth and Alters Immune Markers Compared to Safflower- or Corn Oil-Based Sources of n-6 PUFARahbika Ashraf, Connor D C Buchanan, Lyn M Hillyer, et al.
Plos Medicine|August 25, 2025
Shared decision-making and deprescribing to support anti-thrombotic therapy (dis)continuance for persons living with cancer in their last phase of life: A realist synthesisJustin Jagosh, Mark Pearson, Sarah Greenley, et al.
Pageof 8